{"id":5499,"date":"2020-12-18T18:10:00","date_gmt":"2020-12-18T18:10:00","guid":{"rendered":"https:\/\/irlab.se\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/"},"modified":"2020-12-18T18:10:00","modified_gmt":"2020-12-18T18:10:00","slug":"irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor","status":"publish","type":"post","link":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/","title":{"rendered":"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor"},"content":{"rendered":"<p><span><span><span><span><span>Styrelsen f\u00f6r IRLAB Therapeutics AB (&#8221;IRLAB&#8221; eller &#8221;Bolaget&#8221;) har med st\u00f6d av bemyndigandet fr\u00e5n \u00e5rsst\u00e4mman den 7 maj 2020 beslutat om en riktad nyemission av 3 250 000 aktier av serie A till en teckningskurs om 40 kronor per aktie (&#8221;Nyemissionen&#8221;). Bolaget tillf\u00f6rs genom Nyemissionen 130 000 000 kronor f\u00f6re transaktionskostnader. Teckningskursen motsvarar en rabatt om 3,4 procent j\u00e4mf\u00f6rt med den volymviktade genomsnittskursen f\u00f6r Bolagets aktie under de senaste 15 handelsdagarna fram till och med den 18 december 2020. Nyemissionen har tecknats av bland annat Unionen, Fj\u00e4rde AP-fonden, Daniel Johnsson genom Quiq Holding AB, Nyenburgh Holding, Andra AP-fonden och Handelsbanken Fonder. <\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>&#8221;Efter ett framg\u00e5ngsrikt \u00e5r med en IND godk\u00e4nd i USA, start av fas IIb-studie med mesdopetam och notering p\u00e5 Nasdaq Stockholms huvudlista kommer IRLAB att g\u00e5 in i 2021 med st\u00e4rkt finansiell st\u00e4llning. Ett ut\u00f6kat institutionellt \u00e4gande och en st\u00f6rre kassa ger oss f\u00f6ruts\u00e4ttningar att forts\u00e4tta utveckla bolaget i h\u00f6gre tempo&#8221;, s\u00e4ger Gunnar Olsson, styrelseordf\u00f6rande.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>&#8221;Kapitaltillskottet ger oss m\u00f6jlighet att \u00f6ka takten i v\u00e5ra kliniska studier och p\u00e5skynda f\u00f6rberedelsearbetet f\u00f6r fas III-studier, allt f\u00f6r att minimera tiden till lansering av f\u00e4rdiga l\u00e4kemedel. B\u00e5de mesdopetam och pirepemat-programmen adresserar stora medicinska behov, med betydande potentiell nytta f\u00f6r patienter och \u00f6vriga intressenter&#8221;, s\u00e4ger Nicholas Waters, VD.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Emissionen genomf\u00f6rs med avvikelse fr\u00e5n aktie\u00e4garnas f\u00f6retr\u00e4desr\u00e4tt f\u00f6r att m\u00f6jligg\u00f6ra ett \u00f6kat institutionellt \u00e4gande samt att m\u00f6jligg\u00f6ra st\u00f6rre investeringar i bolagets kliniska projekt i syfte att p\u00e5skynda genereringen av studieresultat samt att inleda f\u00f6rberedelserna f\u00f6r n\u00e4sta utvecklingsfas. Denna riktade emission har dessutom av styrelsen ansetts vara en m\u00f6jlighet att p\u00e5 marknadsm\u00e4ssiga villkor anskaffa kapital p\u00e5 ett tids- och kostnadseffektivt s\u00e4tt. <\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Nyemissionen inneb\u00e4r att antalet aktier i Bolaget \u00f6kar fr\u00e5n 48 498 406 till 51 748 406 aktier, varav 51 668 630 aktier \u00e4r av serie A och 79 776 aktier \u00e4r av serie B, samt att Bolagets aktiekapital \u00f6kar fr\u00e5n 969 968,12 kronor till 1 034 968,12 kronor. Nyemissionen inneb\u00e4r en \u00f6kning av antalet utest\u00e5ende aktier och r\u00f6ster i f\u00f6rh\u00e5llande till det totala antalet utest\u00e5ende aktier respektive r\u00f6ster i Bolaget efter Nyemissionen (utsp\u00e4dning) om cirka 6,3 procent. <\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><strong><span><span><span><span>R\u00e5dgivare<\/span><\/span><\/span><\/span><\/strong><\/span><\/p>\n<p><span><span><span><span><span>Zonda Partners AB har varit Sole Bookrunner, MAQS Advokatbyr\u00e5 har varit legal r\u00e5dgivare till IRLAB och Advokatfirman Vinge har varit legal r\u00e5dgivare till Zonda Partners AB i samband med Nyemissionen. Aktieinvest FK AB&nbsp;\u00e4r emissionsinstitut f\u00f6r Nyemissionen. <\/span><\/span><\/span><\/span><\/span><\/p>\n<p><\/p>\n<p><span><span>Denna information \u00e4r s\u00e5dan som IRLAB Therapeutics AB \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning (EU nr 596\/2014). Informationen l\u00e4mnades, genom angiven kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande <span>2020-12-18 19:10 CET<\/span>.<\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Detta pressmeddelande f\u00e5r inte offentligg\u00f6ras, publiceras eller distribueras, direkt eller indirekt, inom eller till USA, Australien, Hongkong, Japan, Kanada, Nya Zeeland, Schweiz, Singapore, Sydafrika eller n\u00e5gon annan jurisdiktion d\u00e4r s\u00e5dan \u00e5tg\u00e4rd skulle vara olaglig eller f\u00f6rem\u00e5l f\u00f6r legala restriktioner. V\u00e4nligen se viktig information i slutet av pressmeddelandet.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-5499","post","type-post","status-publish","format-standard","hentry","category-pressmeddelande-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor - IRLAB\" \/>\n<meta property=\"og:description\" content=\"Detta pressmeddelande f\u00e5r inte offentligg\u00f6ras, publiceras eller distribueras, direkt eller indirekt, inom eller till USA, Australien, Hongkong, Japan, Kanada, Nya Zeeland, Schweiz, Singapore, Sydafrika eller n\u00e5gon annan jurisdiktion d\u00e4r s\u00e5dan \u00e5tg\u00e4rd skulle vara olaglig eller f\u00f6rem\u00e5l f\u00f6r legala restriktioner. V\u00e4nligen se viktig information i slutet av pressmeddelandet.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-18T18:10:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor\",\"datePublished\":\"2020-12-18T18:10:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/\"},\"wordCount\":461,\"commentCount\":0,\"articleSection\":[\"Pressmeddelande\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/\",\"url\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/\",\"name\":\"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2020-12-18T18:10:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor - IRLAB","og_description":"Detta pressmeddelande f\u00e5r inte offentligg\u00f6ras, publiceras eller distribueras, direkt eller indirekt, inom eller till USA, Australien, Hongkong, Japan, Kanada, Nya Zeeland, Schweiz, Singapore, Sydafrika eller n\u00e5gon annan jurisdiktion d\u00e4r s\u00e5dan \u00e5tg\u00e4rd skulle vara olaglig eller f\u00f6rem\u00e5l f\u00f6r legala restriktioner. V\u00e4nligen se viktig information i slutet av pressmeddelandet.","og_url":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/","og_site_name":"IRLAB","article_published_time":"2020-12-18T18:10:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/#article","isPartOf":{"@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/"},"author":{"name":"","@id":""},"headline":"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor","datePublished":"2020-12-18T18:10:00+00:00","mainEntityOfPage":{"@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/"},"wordCount":461,"commentCount":0,"articleSection":["Pressmeddelande"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/","url":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/","name":"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2020-12-18T18:10:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-genomfor-riktad-emission-om-130-miljoner-kronor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"IRLAB Therapeutics genomf\u00f6r riktad emission om 130 miljoner kronor"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/5499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=5499"}],"version-history":[{"count":0,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/5499\/revisions"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=5499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/categories?post=5499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/tags?post=5499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}